Experienced in Primary Intestinal Lymphangiectasia

Dr. Ehab E. Sorial

Vascular Surgery
111 West Bastanchury Road, Suite 1A, 
Fullerton, CA 
Accepting New Patients
Offers Telehealth
Experienced in Primary Intestinal Lymphangiectasia
111 West Bastanchury Road, Suite 1A, 
Fullerton, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ehab Sorial is a Vascular Surgeon in Fullerton, California. Dr. Sorial is rated as an Experienced provider by MediFind in the treatment of Primary Intestinal Lymphangiectasia. His top areas of expertise are Arterial Insufficiency, Peripheral Artery Disease, Thoracic Aortic Aneurysm, Carotid Artery Surgery, and Angioplasty. Dr. Sorial is currently accepting new patients.

His clinical research consists of co-authoring 11 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Vascular Surgery
Licenses
Vascular Surgery in CA
Hospital Affiliations
Providence Santa Rosa Memorial Hospital
Providence St. Joseph Hospital
Providence St. Jude Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

111 West Bastanchury Road, Suite 1A, Fullerton, CA 92835

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
Enrollment Status: Active_not_recruiting
Publish Date: April 18, 2025
Intervention Type: Drug
Study Phase: Phase 4
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3561774 in Adults With Mixed Dyslipidemia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3561774 in Adults With Mixed Dyslipidemia
Enrollment Status: Completed
Publish Date: March 17, 2025
Intervention Type: Drug
Study Drug: LY3561774
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Ferric Carboxymaltose
Study Phase: Phase 3
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Glargine
Study Phase: Phase 3
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Semaglutide
Study Phase: Phase 3
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis
Enrollment Status: Completed
Publish Date: June 09, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: June 12, 2020
Intervention Type: Drug
Study Phase: Phase 3
Febrile Whole Blood Specimen Collection and Testing Protocol to Demonstrate Product Specificity for the Applied Biosystems™ Bacillus Anthracis Detection Kit
Febrile Whole Blood Specimen Collection and Testing Protocol to Demonstrate Product Specificity for the Applied Biosystems™ Bacillus Anthracis Detection Kit
Enrollment Status: Completed
Publish Date: December 19, 2018
Intervention Type: Device
Lyme Test Indication Combinations (LyTIC) Study
Lyme Test Indication Combinations (LyTIC) Study
Enrollment Status: Terminated
Publish Date: December 13, 2018
Intervention Type: Diagnostic test
Sofia 2 Lyme FIA Whole Blood Clinical Study
Sofia 2 Lyme FIA Whole Blood Clinical Study
Enrollment Status: Completed
Publish Date: March 20, 2018
Intervention Type: Device
View 11 Less Clinical Trials

11 Total Publications

Predictors of Maturation Failure in Arteriovenous Dialysis Access.
Predictors of Maturation Failure in Arteriovenous Dialysis Access.
Journal: Journal of vascular surgery
Published: July 24, 2025
Similar Doctors
Distinguished in Primary Intestinal Lymphangiectasia
Dr. Robert A. Duensing
Vascular Surgery
Distinguished in Primary Intestinal Lymphangiectasia
Dr. Robert A. Duensing
Vascular Surgery
24411 Health Center Drive, Suite 350, 
Laguna Hills, CA 
 (23.4 miles away)
949-457-7900
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Duensing is a Vascular Surgeon in Laguna Hills, California. Dr. Duensing is rated as a Distinguished provider by MediFind in the treatment of Primary Intestinal Lymphangiectasia. His top areas of expertise are Varicose Veins, Lymphedema, Primary Intestinal Lymphangiectasia, Meige Disease, and Carotid Artery Surgery. Dr. Duensing is currently accepting new patients.

Advanced in Primary Intestinal Lymphangiectasia
Dr. Nii-kabu Kabutey
Vascular Surgery | Interventional Radiology | General Surgery
Advanced in Primary Intestinal Lymphangiectasia
Dr. Nii-kabu Kabutey
Vascular Surgery | Interventional Radiology | General Surgery

University Surgeons Of Orange A Medical Group

101 The City Dr S, 
Orange, CA 
 (8.0 miles away)
714-634-5549
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nii-kabu Kabutey is a Vascular Surgeon and an Interventional Radiologist in Orange, California. Dr. Kabutey is rated as a Distinguished provider by MediFind in the treatment of Primary Intestinal Lymphangiectasia. His top areas of expertise are Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm, Peripheral Artery Disease, Angioplasty, and Carotid Artery Surgery.

Advanced in Primary Intestinal Lymphangiectasia
Dr. Peter H. Lin
Vascular Surgery | General Surgery
Advanced in Primary Intestinal Lymphangiectasia
Dr. Peter H. Lin
Vascular Surgery | General Surgery

Vascular Care Specialists Of Los Angeles

901 S Fremont Ave, Suite 218, 
Alhambra, CA 
 (17.8 miles away)
626-269-9993
Languages Spoken:
English
See accepted insurances

Peter Lin is a Vascular Surgeon and a General Surgeon in Alhambra, California. Dr. Lin is rated as an Advanced provider by MediFind in the treatment of Primary Intestinal Lymphangiectasia. His top areas of expertise are End-Stage Renal Disease (ESRD), Gangrene, Varicose Veins, Primary Intestinal Lymphangiectasia, and Carotid Artery Surgery.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sorial's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 15 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile